Payment overview · 2025
General Payments
4 reported records · 4 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · SAFETY HARBOR, FL · NPI 1841277225
Verified facts
CMS Open Payments records show Robert Kaszuba, MD received $93.21 in general payments during 2025 across 4 reported records.
Novo Nordisk Inc accounted for 34.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Paxlovid, Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Trelegy Ellipta by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 143 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 393 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 4 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $32.56 | 34.9% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $24.32 | 26.1% | 1 | 2025 |
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $19.56 | 21.0% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $16.77 | 18.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $93.21 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $32.56 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $24.32 | 1 | 2025 |
Source payment records
|
|||||
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $19.56 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $19.56 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $16.77 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| PAXLOVID paxlovid |
2025 | Paxlovid | 2024 | 13 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 48 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
25 | 23 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
48 | 14 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
143 | 29 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
393 | 83 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
13 | 13 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 599 | 152 |
| Pantoprazole Sodium | Pantoprazole Sodium | 530 | 123 |
| Levothyroxine Sodium | Levothyroxine Sodium | 476 | 80 |
| Gabapentin | Gabapentin | 402 | 75 |
| Eliquis | Apixaban | 393 | 83 |
| Amlodipine Besylate | Amlodipine Besylate | 390 | 112 |
| Trazodone Hcl | Trazodone Hcl | 356 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 281 | 76 |
| Lisinopril | Lisinopril | 273 | 81 |
| Metformin Hcl | Metformin Hcl | 270 | 65 |
| Omeprazole | Omeprazole | 267 | 49 |
| Sertraline Hcl | Sertraline Hcl | 232 | 37 |
| Potassium Chloride | Potassium Chloride | 227 | 53 |
| Losartan Potassium | Losartan Potassium | 218 | 68 |
| Clopidogrel | Clopidogrel Bisulfate | 215 | 70 |
| Cefdinir | Cefdinir | 213 | 153 |
| Oxycodone Hcl | Oxycodone Hcl | 212 | 36 |
| Furosemide | Furosemide | 205 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 198 | 64 |
| Alprazolam | Alprazolam | 196 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 191 | 55 |
| Simvastatin | Simvastatin | 189 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 178 | 54 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 171 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 169 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 165 | 52 |
| Clonidine Hcl | Clonidine Hcl | 154 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 154 | 47 |
| Azithromycin | Azithromycin | 150 | 71 |
| Quetiapine Fumarate | Quetiapine Fumarate | 150 | 22 |
| Divalproex Sodium | Divalproex Sodium | 149 | 17 |
| Carvedilol | Carvedilol | 148 | 42 |
| Famotidine | Famotidine | 146 | 30 |
| Xarelto | Rivaroxaban | 145 | 34 |
| Ozempic | Semaglutide | 143 | 29 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 141 | 24 |
| Buspirone Hcl | Buspirone Hcl | 140 | 27 |
| Levetiracetam | Levetiracetam | 138 | 26 |
| Montelukast Sodium | Montelukast Sodium | 135 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 127 | 59 |
| Mirtazapine | Mirtazapine | 126 | 34 |
| Ondansetron Hcl | Ondansetron Hcl | 125 | 46 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 116 | 31 |
| Dicyclomine Hcl | Dicyclomine Hcl | 116 | 19 |
| Prednisone | Prednisone | 116 | 62 |
| Spironolactone | Spironolactone | 116 | 31 |
| Baclofen | Baclofen | 114 | 22 |
| Diazepam | Diazepam | 110 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 98 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 97 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 92 | 21 |
| Topiramate | Topiramate | 91 | suppressed |
| Lactulose | Lactulose | 89 | 20 |
| Naproxen | Naproxen | 87 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 85 | 30 |
| Olanzapine | Olanzapine | 84 | suppressed |
| Clonazepam | Clonazepam | 83 | 19 |
| Lamotrigine | Lamotrigine | 80 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 78 | 13 |
| Meloxicam | Meloxicam | 78 | 14 |
| Nifedipine Er | Nifedipine | 77 | 24 |
| Jardiance | Empagliflozin | 73 | 18 |
| Allopurinol | Allopurinol | 69 | 19 |
| Fenofibrate | Fenofibrate | 69 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 69 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 69 | 24 |
| Ezetimibe | Ezetimibe | 68 | 19 |
| Lubiprostone | Lubiprostone | 67 | suppressed |
| Risperidone | Risperidone | 67 | 11 |
| Celecoxib | Celecoxib | 66 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 66 | 13 |
| Linzess | Linaclotide | 62 | suppressed |
| Ondansetron Odt | Ondansetron | 61 | 28 |
| Alendronate Sodium | Alendronate Sodium | 60 | 12 |
| Bumetanide | Bumetanide | 59 | 12 |
| Temazepam | Temazepam | 57 | 14 |
| Finasteride | Finasteride | 56 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 56 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 56 | 12 |
| Digoxin | Digoxin | 55 | suppressed |
| Lidocaine | Lidocaine | 55 | suppressed |
| Lorazepam | Lorazepam | 55 | 17 |
| Oxycontin | Oxycodone Hcl | 55 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 42 |
| Ketoconazole | Ketoconazole | 54 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 53 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | 11 |
| Atenolol | Atenolol | 52 | 13 |
| Gemtesa | Vibegron | 52 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 52 | suppressed |
| Nystatin | Nystatin | 51 | 26 |
| Sucralfate | Sucralfate | 51 | 11 |
| Januvia | Sitagliptin Phosphate | 50 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 49 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 49 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 49 | 15 |
| Donepezil Hcl | Donepezil Hcl | 48 | 14 |
| Meclizine Hcl | Meclizine Hcl | 48 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 48 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | 12 |
| Ibuprofen | Ibuprofen | 45 | 18 |
| Pregabalin | Pregabalin | 45 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 33 |
| Entresto | Sacubitril/Valsartan | 44 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 44 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 43 | 22 |
| Prazosin Hcl | Prazosin Hcl | 42 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | suppressed |
| Latanoprost | Latanoprost | 41 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | 28 |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Fluconazole | Fluconazole | 40 | 28 |
| Glipizide | Glipizide | 40 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 40 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | 11 |
| Tramadol Hcl | Tramadol Hcl | 40 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | 13 |
| Guanfacine Hcl Er | Guanfacine Hcl | 39 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 38 | suppressed |
| Methylprednisolone | Methylprednisolone | 38 | 32 |
| Ropinirole Hcl | Ropinirole Hcl | 38 | 11 |
| Amoxicillin | Amoxicillin | 37 | 22 |
| Torsemide | Torsemide | 37 | suppressed |
| Synthroid | Levothyroxine Sodium | 36 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 35 | suppressed |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Mupirocin | Mupirocin | 34 | 19 |
| Xifaxan | Rifaximin | 34 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 33 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 27 |
| Levemir Flexpen | Insulin Detemir | 33 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 33 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 32 | 16 |
| Haloperidol | Haloperidol | 32 | suppressed |
| Scopolamine | Scopolamine | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 13 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 16 |
| Valsartan | Valsartan | 31 | suppressed |
| Vascepa | Icosapent Ethyl | 31 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 30 | suppressed |
| Primidone | Primidone | 30 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 29 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 29 | 11 |
| Atomoxetine Hcl | Atomoxetine Hcl | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 27 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 26 | suppressed |
| Repatha Sureclick | Evolocumab | 26 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 25 | 23 |
| Cephalexin | Cephalexin | 25 | 18 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 11 |
| Acyclovir | Acyclovir | 24 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 23 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 22 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Tradjenta | Linagliptin | 21 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 20 | suppressed |
| Constulose | Lactulose | 20 | suppressed |
| Ertapenem | Ertapenem Sodium | 20 | 16 |
| Nitroglycerin | Nitroglycerin | 20 | 17 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | suppressed |
| Tobramycin | Tobramycin | 18 | 15 |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 15 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | suppressed |
| Clozapine | Clozapine | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Glucagon Emergency Kit | Glucagon | 14 | suppressed |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 11 |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | 13 |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Neupro | Rotigotine | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Otezla | Apremilast | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Trulance | Plecanatide | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Minoxidil | Minoxidil | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Procrit | Epoetin Alfa | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 11 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 11 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $93.21 · 4 records | Novo Nordisk Inc | Natroba, PAXLOVID, Spinosad, TRELEGY ELLIPTA, Wegovy | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error